trending Market Intelligence /marketintelligence/en/news-insights/trending/_gIq0xcxrRZHRk0P57je1g2 content esgSubNav
In This List

Medtronic gets FDA approval for cardiac mapping system

Blog

Insight Weekly: Ukraine war impact on mining; US bank growth slowdown; cloud computing headwinds

Blog

Insight Weekly: Cryptocurrency's growth; green bond market outlook; coal investors' windfall

Blog

Global M&A By the Numbers: Q1 2022

Blog

Insight Weekly: Challenges for European banks; Japan's IPO slowdown; carmakers' supply woes


Medtronic gets FDA approval for cardiac mapping system

Medtronic plc received 510(k) clearance from the U.S. FDA for its noninvasive cardiac mapping system.

The company will employ a strategic rollout of the technology in the geographies where it is cleared.

The CardioInsight noninvasive 3D mapping system is used for mapping of irregular heart rhythms in the upper and lower chambers of the heart. It also provides electroanatomic 3D maps of the heart.